 | | PRD_000913 | | Name: | M4Z inhibitor | | Formula: | C24 H39 N7 O6 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000930 | | Name: | N-hexanoyl-L-valyl-N~1~-[(2R,3S,4S)-1,3-dihydroxy-2,6-dimethylheptan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | | Formula: | C27 H52 N4 O6 | | Description: | epoxyketone carmaphycin analogue 3, bound form | | Definition date: | 2014-01-29 | | Last modified: | 2023-11-03 |
|
 | | PRD_000935 | | Name: | N-[(benzyloxy)carbonyl]-6-diazonio-5-oxo-L-norleucyl-L-valyl-L-prolyl-L-leucine | | Formula: | C30 H43 N6 O8 | | Definition date: | 2013-06-26 | | Last modified: | 2023-11-03 |
|
 | | PRD_001064 | | Name: | N-(tert-butylcarbamoyl)-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-phenylquinolin-4-yl)oxy]-L-prolinamide | | Formula: | C38 H47 N5 O7 | | Definition date: | 2014-03-26 | | Last modified: | 2023-11-03 |
|
 | | PRD_000292 | | Name: | BETA-SECRETASE INHIBITOR NVP-AMK640 | | Formula: | C29 H50 N6 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_002132 | | Name: | (10S,13S,16S,19S)-16-benzyl-12-(N-methyl-L-alanyl-L-valyl)-3,14,17-trioxo-2,7,8,9,12,15,18-heptaazatetracyclo[19.2.2.1~6,9~.1~10,13~]heptacosa-1(23),6(27),7,21,24-pentaene-19-carboxylic acid | | Formula: | C37 H47 N9 O7 | | Definition date: | 2015-03-04 | | Last modified: | 2023-11-03 |
|
 | | PRD_002156 | | Name: | N-acetyl-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | | Formula: | C24 H45 N5 O6 | | Definition date: | 2016-03-16 | | Last modified: | 2023-11-03 |
|
 | | PRD_002173 | | Name: | N-methyl-L-valyl-N-[(3R,4S,5S)-1-{(2S)-2-[(1R,2R)-3-{[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino}-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl}-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N-methyl-L-valinamide | | Formula: | C39 H67 N5 O7 | | Definition date: | 2016-07-27 | | Last modified: | 2023-11-03 |
|
 | | PRD_002214 | | Formula: | C35 H48 N6 O8 | | Definition date: | 2015-12-02 | | Last modified: | 2023-11-03 |
|
 | | PRD_002239 | | Name: | N-[5-(2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoyl]-L-valyl-L-leucyl-N-[(3R)-7-amino-2-oxoheptan-3-yl]-L-threoninamide | | Formula: | C32 H57 N7 O7 S | | Definition date: | 2017-08-02 | | Last modified: | 2023-11-03 |
|
 | | PRD_000845 | | Name: | N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-4-[(8-bromo-7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-L-prolinamide | | Formula: | C40 H49 Br N6 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000849 | | Name: | N-[(cyclopentyloxy)carbonyl]-3-methyl-L-valyl-(4R)-N-[(1R,2S)-1-carboxy-2-ethenylcyclopropyl]-4-[(7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-L-prolinamide | | Formula: | C40 H50 N6 O9 S | | Definition date: | 2012-12-12 | | Last modified: | 2023-11-03 |
|
 | | PRD_000219 | | Name: | GRAMICIDIN S | | Formula: | C60 H92 N12 O10 | | Description: | GRAMICIDIN S IS A DECAPEPTIDE,
RESIDUES 1 AND 10 FORM A PEPTIDE BOND
RESULTING IN CYCLIZATION. | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000220 | | Name: | FEGLYMYCIN | | Formula: | C95 H97 N13 O30 | | Description: | FEGLYMYCIN IS A LINEAR HELICAL TRIDECAMER PEPTIDE | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000239 | | Name: | N-acetyl-L-alpha-aspartyl-L-valyl-N-[(1S)-1-(carboxymethyl)-3-fluoro-2-oxopropyl]-L-alaninamide | | Formula: | C19 H29 F N4 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000243 | | Name: | N-acetyl-3-(naphthalen-1-yl)-L-alanyl-L-valyl-L-leucyl-L-alanyl-L-alpha-glutamyl-3-naphthalen-1-yl-
L-alaninamide | | Formula: | C47 H59 N7 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000245 | | Name: | 1-acetyl-L-prolyl-L-prolyl-L-prolyl-L-valyl-N-(1-methylethyl)glycyl-L-prolyl-N~5~-[amino(iminio)methyl]-L-ornithyl-
N~5~-[amino(iminio)methyl]-L-ornithine | | Formula: | C44 H76 N14 O10 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000250 | | Name: | N-acetyl-L-valyl-O-benzyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-{[(3R)-2-oxopyrrolidin-3-yl]methyl}propyl]-L-leucinamide | | Formula: | C32 H51 N5 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000252 | | Name: | Ac-Tyr-Val-Ala-Asp-Aldehyde | | Formula: | C23 H32 N4 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000272 | | Name: | CBZ-DEHYDRO-LEU-VAL-ARG-TYR | | Formula: | C34 H50 N7 O8 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000278 | | Name: | DECANOYL-ARG-VAL-LYS-ARG-CHLOROMETHYLKETONE | | Formula: | C34 H71 Cl N11 O5 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000283 | | Name: | N-(6-aminohexanoyl)-3-methyl-L-valyl-3-methyl-L-valyl-N~1~-[(2S,3S)-3-hydroxy-4-oxo-4-{[(1R)-1-phenylpropyl]amino}butan-2-yl]-N~4~,N~4~-dimethyl-L-aspartamide | | Formula: | C37 H63 N7 O7 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000286 | | Name: | D-valyl-N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-L-leucinamide | | Formula: | C18 H36 Cl N4 O3 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000290 | | Name: | BETA-SECRETASE INHIBITOR OM99-2 | | Formula: | C41 H64 N8 O14 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
 | | PRD_000298 | | Name: | N-[(2R)-3-phenyl-2-{[L-prolyl-L-phenylalanyl-3-(1H-imidazol-3-ium-4-yl)-L-alanyl]amino}propyl]-L-phenylalanyl-L-valyltyrosine | | Formula: | C58 H72 N12 O9 | | Definition date: | 2012-12-12 | | Last modified: | 2023-09-20 |
|
